🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib trial tests the safety, side effects, and best dose of iberdo...
Status
Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2024-12-06
Trial ID
NCT06465316
This phase IIa trial compares the safety and effect of temozolomide combine...
Status
Suspended
Location
Roswell Park Cancer Institute
Start Date
2026-10-15
Trial ID
NCT06202066
This is primarily an observational trial in patients with chronic anemia sy...
Status
Completed
Location
CHLA
Start Date
2018-07-15
Trial ID
NCT03715972
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of iberdomide ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-28
Trial ID
NCT07437963
This phase II trial compares epcoritamab to standard practice (observation)...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2024-01-31
Trial ID
NCT06238648
This study evaluates the impact of ofatumumab in Relapsing Remitting Multip...
Status
Completed
Location
MD First Research
Start Date
2022-01-25
Trial ID
NCT05084638
Treatments Being Tested
This pilot phase I trial studies the side effects of taking ipilimumab afte...
Status
Terminated
Location
Jonsson Comprehensive Cancer Center
Start Date
2014-07-17
Trial ID
NCT02070406
This early phase I trial tests the safety and how well N-803 works in treat...
Status
Recruiting
Location
Northwestern University
Start Date
2026-04-13
Trial ID
NCT07261657
Primary Objective: To determine the efficacy of SAR441344 as measured by r...
Status
Active Not Recruiting
Location
Center for Neurology and Spine- Site Number : 8400007
Start Date
2021-06-07
Trial ID
NCT04879628
Treatments Being Tested
This phase II/III trial tests adding glofitamab to standard of care chemoim...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-30
Trial ID
NCT07724457
Treatments Being Tested